Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of ACT-541468 in adult and elderly subjects with insomnia disorder
2017-004643-20Phase 3Completed
- Sponsor
- Idorsia
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daridorexant in Insomnia, sponsored by Idorsia. Started Mar 2018; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2017-004643-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004643-20.